Vanda Pharmaceuticals reported $58.23M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Acorda Therapeutics ACOR:US $ 23.13M 8.75M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Akebia Therapeutics AKBA:US $ 143.89M 30.67M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Anika Therapeutics ANIK:US $ 91.39M 1.07M
Arrowhead Research ARWR:US $ 139.44M 53.03M
AstraZeneca AZN:LN 4817M 945M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Clovis Oncology CLVS:US $ 94.58M 27.66M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Enanta Pharmaceuticals ENTA:US $ 28.37M 12.62M
Esperion Therapeutics ESPR:US $ 122.94M 27.42M
Halozyme Therapeutics HALO:US $ 90.93M 26.9M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Insmed INSM:US $ 416.08M 99.63M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
Lexicon Pharmaceuticals LXRX:US $ 61.97M 2.45M
Ligand Pharmaceuticals LGND:US $ 153.22M 138.22M
Minerva Neurosciences NERV:US $ 49.75M 5.19M
Moderna Inc MRNA:US 2.87B 2.18B
Novartis NVS:US $ 3625M 10227M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Puma Biotechnology PBYI:US $ 52.76M 11.16M
Sangamo Biosciences SGMO:US $ 117.7M 2.55M
Takeda 4502:JP Y 645991M 203704M
Teva Pharmaceutical TEVA:IT 2.06B 117M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vanda Pharmaceuticals VNDA:US $ 58.23M 8.7M
Veracyte VCYT:US $ 153.45M 10.17M